Global Human Insulin Drugs and Delivery Devices Market Size study, by Drug Type, by Device Type and Regional Forecasts 2022-2028

Description

List of Tables

Global Human Insulin Drugs and Delivery Devices Market is valued at approximately USD 40.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3% over the forecast period 2022-2028. Protein hormone insulin helps people whose systems are unable to manufacture enough insulin control high blood sugar levels. By enhancing glucose uptake in fatty tissues and muscles, insulin reduces the blood glucose level. This can be infused in buttocks, belly, backs of the arms, or legs. Additionally, insulin not only aids in the management of diabetes but also in the treatment of its immediate consequences, including diabetic ketoacidosis and hyperosmolar hyperglycemia. The market growth is driven by key factors such as growth in the number of diabetic patients and rising market demand for HI Analogs. According to a Commonwealth Fund study, Americans with diabetes who lack insurance are more likely to use older, less expensive (and less effective) insulin medications than those who have Medicaid or private insurance. 60% to 80% of people without insurance pay the entire list price for insulin, compared to 9% of privately insured patients and 3% of Medicaid recipients. Moreover, expected patent expiry of key HI Drugs propels the market opportunities across the globe. However, stringent regulatory requirements for product approval impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Human Insulin Drugs and Delivery Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to high cases and increasing amount of diabetic patients. However, Asia Pacific is expected to be the fastest growing region due to changing lifestyles of people and unhealthy dietary habits.

Major market players included in this report are:

Novo Nordisk A/S

Insulet

Eli Lilly

Exir

Biocon

Becton Dickinson

Medtronic

Ypsomed

Julphar

Sanofi Aventis

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Basal or Long-acting Insulins

Bolus or Fast-acting Insulins

Traditional Human Insulins

Combination Insulins

Biosimilar Insulins

By Device Type:

Insulin Pens

Insulin Pumps

Insulin Syringes

Jet Injectors

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Human Insulin Drugs and Delivery Devices Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Human Insulin Drugs and Delivery Devices Market, by region, 2020-2028 (USD Billion)
- 1.2.2. Human Insulin Drugs and Delivery Devices Market, by Drug Type, 2020-2028 (USD Billion)
- 1.2.3. Human Insulin Drugs and Delivery Devices Market, by Device Type, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Human Insulin Drugs and Delivery Devices Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Human Insulin Drugs and Delivery Devices Market Dynamics

3.1. Human Insulin Drugs and Delivery Devices Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
  - 3.1.1.1. Growth in the Number of Diabetic Patients
  - 3.1.1.2. Rising Market Demand for HI Analogs
- 3.1.2. Market Challenges
  - 3.1.2.1. Stringent Regulatory Requirements for Product Approval
- 3.1.3. Market Opportunities
  - 3.1.3.1. Expected Patent Expiry of Key HI Drugs
  - 3.1.3.2. Emerging Markets

Chapter 4. Global Human Insulin Drugs and Delivery Devices Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Human Insulin Drugs and Delivery Devices Market, by Drug Type

6.1. Market Snapshot
6.2. Global Human Insulin Drugs and Delivery Devices Market by Drug Type, Performance - Potential Analysis
6.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Drug Type, 2018-2028 (USD Billion)
6.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
- 6.4.1. Basal or Long-acting Insulins
- 6.4.2. Bolus or Fast-acting Insulins
- 6.4.3. Traditional Human Insulins
- 6.4.4. Combination Insulins
- 6.4.5. Biosimilar Insulins

Chapter 7. Global Human Insulin Drugs and Delivery Devices Market, by Device Type

7.1. Market Snapshot
7.2. Global Human Insulin Drugs and Delivery Devices Market by Device Type, Performance - Potential Analysis
7.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Device Type, 2018-2028 (USD Billion)
7.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
- 7.4.1. Insulin Pens
- 7.4.2. Insulin Pumps
- 7.4.3. Insulin Syringes
- 7.4.4. Jet Injectors

Chapter 8. Global Human Insulin Drugs and Delivery Devices Market, Regional Analysis

8.1. Human Insulin Drugs and Delivery Devices Market, Regional Market Snapshot
8.2. North America Human Insulin Drugs and Delivery Devices Market
- 8.2.1. U.S. Human Insulin Drugs and Delivery Devices Market
  - 8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2028
  - 8.2.1.2. Device Type breakdown estimates & forecasts, 2018-2028
- 8.2.2. Canada Human Insulin Drugs and Delivery Devices Market
8.3. Europe Human Insulin Drugs and Delivery Devices Market Snapshot
- 8.3.1. U.K. Human Insulin Drugs and Delivery Devices Market
- 8.3.2. Germany Human Insulin Drugs and Delivery Devices Market
- 8.3.3. France Human Insulin Drugs and Delivery Devices Market
- 8.3.4. Spain Human Insulin Drugs and Delivery Devices Market
- 8.3.5. Italy Human Insulin Drugs and Delivery Devices Market
- 8.3.6. Rest of Europe Human Insulin Drugs and Delivery Devices Market
8.4. Asia-Pacific Human Insulin Drugs and Delivery Devices Market Snapshot
- 8.4.1. China Human Insulin Drugs and Delivery Devices Market
- 8.4.2. India Human Insulin Drugs and Delivery Devices Market
- 8.4.3. Japan Human Insulin Drugs and Delivery Devices Market
- 8.4.4. Australia Human Insulin Drugs and Delivery Devices Market
- 8.4.5. South Korea Human Insulin Drugs and Delivery Devices Market
- 8.4.6. Rest of Asia Pacific Human Insulin Drugs and Delivery Devices Market
8.5. Latin America Human Insulin Drugs and Delivery Devices Market Snapshot
- 8.5.1. Brazil Human Insulin Drugs and Delivery Devices Market
- 8.5.2. Mexico Human Insulin Drugs and Delivery Devices Market
8.6. Rest of The World Human Insulin Drugs and Delivery Devices Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Company Profiles
- 9.2.1. Sanofi Aventis
  - 9.2.1.1. Key Information
  - 9.2.1.2. Overview
  - 9.2.1.3. Financial (Subject to Data Availability)
  - 9.2.1.4. Product Summary
  - 9.2.1.5. Recent Developments
- 9.2.2. Novo Nordisk A/S
- 9.2.3. Insulet
- 9.2.4. Eli Lilly
- 9.2.5. Exir
- 9.2.6. Biocon
- 9.2.7. Becton Dickinson
- 9.2.8. Medtronic
- 9.2.9. Ypsomed
- 9.2.10. Julphar

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Human Insulin Drugs and Delivery Devices Market, report scope
TABLE 2. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Drug Type 2018-2028 (USD Billion)
TABLE 4. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Device Type 2018-2028 (USD Billion)
TABLE 5. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 6. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 17. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 19. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 22. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 25. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 28. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 31. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 34. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 37. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 40. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 43. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 46. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 49. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 52. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Human Insulin Drugs and Delivery Devices Market
TABLE 55. List of primary sources, used in the study of global Human Insulin Drugs and Delivery Devices Market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

FIG 1. Global Human Insulin Drugs and Delivery Devices Market, research methodology
FIG 2. Global Human Insulin Drugs and Delivery Devices Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Human Insulin Drugs and Delivery Devices Market, key trends 2021
FIG 5. Global Human Insulin Drugs and Delivery Devices Market, growth prospects 2022-2028
FIG 6. Global Human Insulin Drugs and Delivery Devices Market, porters 5 force model
FIG 7. Global Human Insulin Drugs and Delivery Devices Market, pest analysis
FIG 8. Global Human Insulin Drugs and Delivery Devices Market, value chain analysis
FIG 9. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Human Insulin Drugs and Delivery Devices Market, regional snapshot 2018 & 2028
FIG 15. North America Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
FIG 16. Europe Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
FIG 19. Global Human Insulin Drugs and Delivery Devices Market, company market share analysis (2021)